Study
Study at UCL
Being a student at UCL is about so much more than just acquiring knowledge. Studying here gives you the opportunity to realise your potential as an individual, and the skills and tools to thrive.
Research
Research at UCL
Find out more about what makes UCL research world-leading, how to access UCL expertise, and teams in the Office of the Vice-Provost (Research, Innovation and Global Engagement).
Engage
Engage with UCL
Discover the many ways you can connect with UCL, and how we work with industry, government and not-for-profit organisations to tackle tough challenges.
About
About UCL
Founded in 1826 in the heart of London, UCL is London's leading multidisciplinary university, with more than 16,000 staff and 50,000 students from 150 different countries.

Prenatal Therapy

Professor Anna David leads a team developing prenatal treatment of severe early onset and life-threatening disorders using gene and cellular therapy, and to investigate the efficacy, safety and ethical issues of such treatment.

Background

Research into fetal gene therapy began under a 5 year MRC Programme grant (Professor Charles Rodeck) in collaboration with the Gene Therapy Research Group (Professor Charles Coutelle) at Imperial College, London in 2000. Professor David obtained a PhD on clinically applicable methods of delivering fetal gene therapy in 2005 at UCL and she established the group in 2007.

Research Projects

Research Projects

Current Research Projects

Research Students

A list of current research students

Publications

List of publications

Professor Anna David

Research Group Lead

Iris profile

Anna David, Director, Institute of Women's Health, UCL

Twitter

@PrenatalTherapy: Obstetrician and specialist in maternal fetal medicine, with an interest in developing prenatal therapies for pregnancy complications and congenital disease

@FP7EVERREST: Does vascular endothelial growth factor gene therapy safely improve outcome in severe early-onset fetal growth restriction?